66111-52-2

Upstream product

• 76379-00-5 N-tert-butoxycarbonyl-D-glutamic acid α-p-nitrophenyl-γ-benzyl ester 
• 35793-73-8 N-(tert-butyloxycarbonyl)-γ-benzyl-D-glutamic acid 
• 2578-33-8 D-glutamic acid-5-benzyl ester 
• 18800-73-2 benzyl (R)-5-amino-4-((tert-butoxycarbonyl)amino)-5-oxopentanoate 
• 15260-10-3 N-Boc-O-benzyl-L-threonine 
• 71811-14-8 D-Glutaminsaeure-α-amid-γ-benzylester 
• 76398-76-0 N-(t-butoxycarbonyl)-O-benzyl-L-threonine N-hydroxy-5-norbornene-2,3-dicarboximide ester 

Downstream Products

• 66111-85-1 (R)-4-{(2S,3R)-2-[(R)-2-((4aR,6S,7R,8R,8aS)-7-Acetylamino-6-benzyloxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy)-propionylamino]-3-benzyloxy-butyrylamino}-4-carbamoyl-butyric acid benzyl ester 
• 139753-68-7 (R)-4-((2S,3R)-2-Amino-3-benzyloxy-butyrylamino)-4-carbamoyl-butyric acid benzyl ester 

Relevant academic research and scientific papers

Novel immunological adjuvant compounds and methods of preparation thereof

This application relates to novel immunological adjuvant compounds of the formula: STR1 wherein each of R and R1 are the same or different and are hydrogen or an acyl radical; R2 is an unsubstituted or substituted alkyl radical, or an unsubstituted or substituted aryl radical; X is an aminoacyl moiety; and Y is D-isoasparagine or D-isoglutamine.